Old National Bancorp Vbi Vaccines Inc Transaction History

Old National Bancorp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 19, 2023	SELL	$0.29 - $0.64 $7,249 - $16,000	-25,000 Reduced 33.16%	50,382 $15,000
Q4 2022 Feb 03, 2023	SELL	$0.38 - $22.5 $12,956 - $767,137	-34,095 Reduced 31.14%	75,382 $29,000
Q3 2022 Feb 17, 2023	BUY	$0.73 - $23.4 $24,889 - $797,823	34,095 Added 45.23%	109,477 $77,000
Q2 2022 Jul 25, 2022	BUY	$0.66 - $1.81 $72,254 - $198,153	109,477 New	109,477 $89,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

Stay updated on Old National Bancorp with notifications on news.